Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
SRM Portfolio Pvt Ltd has submitted the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE:17-02-2012
17-02-2012
Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992
AKJ Portfolio Pvt Ltd, NRM Portfolio Pvt Ltd, GM Portfolio Pvt Ltd, VRM Portfolio Pvt Ltd, VKM Portfolio Pvt Ltd, SRM Portfolio Pvt Ltd has submitted the disclosure under Regulation 13(4), 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:17-02-2012
Outcome of Board Meeting
Ind-Swift Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 08, 2012, inter alia, has approved the following:1. Allotted 40,00,000 equity shares (par value Rs. 2/- each) to the Promoter Group entities upon conversion of 40,00,000 Zero Coupon Optionally Convertible Warrants (2010 Series) at a price of Rs. 40/- per share....14-02-2012
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Ind-Swift Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:10-02-2012
Financial Results for Dec 31, 2011
Ind-Swift Ltd has informed BSE about the Financial Results for the period ended December 31, 2011.08-02-2012
Board Meeting on Feb 08, 2012
Ind-Swift Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 08, 2012, inter alia, to consider and take on record the Un-audited Financial results of the Company for the Quarter ended on December 31, 2011 & also to consider the allotment of shares upon part conversion of Zero Coupon Convertible Warrants.03-02-2012
ROCHE DIAGNOSTICS enters into agreement with ISL to expand TROP T Rapid assay adoption in India
Ind-Swift Ltd has informed BSE regarding a press release dated January 13, 2012, titled "ROCHE DIAGNOSTICS enters into agreement with ISL to expand TROP T Rapid assay adoption in India".Press Release :"Roche Diagnostics India Pvt. Ltd. enters into an agreement with Ind-Swift Limited; a Chandigarh based pharmaceutical company to promote its test for detecting heart attack, TROP T rapid assay, in India. Roche Diagnostics India Pvt....16-01-2012
Outcome of Board Meeting
Ind-Swift Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 14, 2011 inter alia, has Granted its in-principle approval for amalgamation of the Company with (i) Essix biosciences Ltd, (ii). Dashmesh Medicare Pvt. Ltd (Both unlisted entities) under section 391 to 394 of the Companies Act, 1956, subject to appropriate statutory and regulatory approvals.15-11-2011
Financial Results for Sep 30, 2011
Ind-Swift Ltd has informed BSE about the Financial Results for the period ended September 30, 2011.14-11-2011
Outcome of AGM
Ind-Swift Ltd has informed BSE that the shareholders of the Company have taken following decisions at the Annual General Meeting (AGM) held on September 26, 2011, :1. Approved and adopted the Balance Sheet as at March 31, 2011 and the Profit & Loss Account of the Company for the year ended on that date and the reports of Directors and Auditors thereon....27-09-2011